Skip to content
  • The Podcasts:
  • CME
  • The Rising Tide
    • Register For a Tailored Experience
    • S2-E2 – A Deeper Dive Into Fatty Liver, NAFLD, and NASH
    • S2-E1 – Combating Swelling NAFLD and NASH Prevalence: Drugs, Diagnostics and Guidelines for the Frontline
    • S1-E3 – Diabetes Drug Choices With Benefits For NAFLD
    • S1-E2 — What’s Behind The New AACE Fatty Liver Guidelines?
    • S1-E1 – Growing NAFLD-Diabetes Dual Prevalence Increases CVD Risk for Diabetics
  • NASH Tsunami
    • Season 4 (2023)
    • Season 3 (2022)
      • Year In Review 2022
    • Season 2 (2021)
      • Year In Review 2021
    • Season 1 (2020)
      • Year In Review 2020
    • Most Popular Episodes
Menu
  • The Podcasts:
  • CME
  • The Rising Tide
    • Register For a Tailored Experience
    • S2-E2 – A Deeper Dive Into Fatty Liver, NAFLD, and NASH
    • S2-E1 – Combating Swelling NAFLD and NASH Prevalence: Drugs, Diagnostics and Guidelines for the Frontline
    • S1-E3 – Diabetes Drug Choices With Benefits For NAFLD
    • S1-E2 — What’s Behind The New AACE Fatty Liver Guidelines?
    • S1-E1 – Growing NAFLD-Diabetes Dual Prevalence Increases CVD Risk for Diabetics
  • NASH Tsunami
    • Season 4 (2023)
    • Season 3 (2022)
      • Year In Review 2022
    • Season 2 (2021)
      • Year In Review 2021
    • Season 1 (2020)
      • Year In Review 2020
    • Most Popular Episodes
Bars

Contact Surfing NASH


Listen Now

Apple Spotify Youtube
Copyright © SurfingNASH.Com 2020—2023
Linkedin Facebook Twitter Instagram
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT
Apple Spotify Youtube Soundcloud
  • Member Log In
  • Sponsorships
    • Our Sponsors & Affiliates
    • Sponsorship Programs
  • Surfers
  • Contact
Menu
  • Member Log In
  • Sponsorships
    • Our Sponsors & Affiliates
    • Sponsorship Programs
  • Surfers
  • Contact
  • March 23, 2023

S4-14 – Previewing the 2023 Innovations in NAFLD Care Workshop

  • March 19, 2023

S4-12.6 – From the Vault: Building a Disease Model for NASH Prevalence: Key Challenges

  • March 19, 2023

S4-12.5 – ICER Draft Report: Different Stakeholder Impacts

  • March 19, 2023

S4-12.4 – Biopsy, Biomarkers and Assessing the Value and Pricing of New Medications

  • March 18, 2023

S4-12.3 – Keeping Regulatory Pace with Field Advancements

  • March 18, 2023

S4-12.2 – ICER Draft Report: Assessment of Disease Prevalence and Prospective Drug Efficacy

  • March 18, 2023

S4-12.1 – Introducing the ICER Draft Report on Resmetirom and Obeticholic Acid for NASH

  • March 16, 2023

S4-12 – Deep Dive: ICER Draft Report on Resmetirom and Obeticholic Acid for NASH

  • March 12, 2023

S4-11.6 – From the Vault: #NASHDay 2022 Preview: SurfingNASH Predictions

  • March 12, 2023

S4-11.5 – Excitement and Trepidations: Exploring the Year Ahead in Fatty Liver

More Episodes
Log In
  • The Podcasts:
  • CME
  • The Rising Tide
    • Register For a Tailored Experience
    • S2-E2 – A Deeper Dive Into Fatty Liver, NAFLD, and NASH
    • S2-E1 – Combating Swelling NAFLD and NASH Prevalence: Drugs, Diagnostics and Guidelines for the Frontline
    • S1-E3 – Diabetes Drug Choices With Benefits For NAFLD
    • S1-E2 — What’s Behind The New AACE Fatty Liver Guidelines?
    • S1-E1 – Growing NAFLD-Diabetes Dual Prevalence Increases CVD Risk for Diabetics
  • NASH Tsunami
    • Season 4 (2023)
    • Season 3 (2022)
      • Year In Review 2022
    • Season 2 (2021)
      • Year In Review 2021
    • Season 1 (2020)
      • Year In Review 2020
    • Most Popular Episodes
  • Member Log In
  • Sponsorships
    • Our Sponsors & Affiliates
    • Sponsorship Programs
  • Surfers
  • Contact
Stay In Touch
Apple Spotify Youtube

Experience Nudge Learning! Interested in a new way of learning?

Learn More About CME